How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma

How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local treatment, such as surgical resection, liver transplant, and local ablation, has improved the survival of patients with HCC detected at an early stage. Until recently, the treatment of patients with meta...

Full description

Bibliographic Details
Main Authors: Giulia Martini, Davide Ciardiello, Fernando Paragliola, Valeria Nacca, Walter Santaniello, Fabrizio Urraro, Maria Stanzione, Marco Niosi, Marcello Dallio, Alessandro Federico, Francesco Selvaggi, Carminia Maria Della Corte, Stefania Napolitano, Fortunato Ciardiello, Erika Martinelli
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
HCC
immune checkpoint inhibitors
multimodal treatment
biomarkers
AFP
Online Access:https://www.mdpi.com/2072-6694/13/18/4719

Internet

https://www.mdpi.com/2072-6694/13/18/4719

Similar Items